NIR II light-driven nanomotor synergistically enhances immunogenic cell death through photothermal and chemodynamic therapy for melanoma immunotherapy
Xuan Hu,
No information about this author
Ziyan Shen,
No information about this author
H. Hao
No information about this author
et al.
Journal of Colloid and Interface Science,
Journal Year:
2025,
Volume and Issue:
694, P. 137688 - 137688
Published: April 23, 2025
Language: Английский
Integration of Fe(III)-Chelated Polydopamine and Diallyl Trisulfide for Boosting Ferroptosis to Reverse Multidrug Resistance and Inducing Synergistic Tumor Nanotherapy
Yiwang Zhao,
No information about this author
Shunyu Yao,
No information about this author
Jing Huang
No information about this author
et al.
ACS Applied Nano Materials,
Journal Year:
2024,
Volume and Issue:
7(22), P. 25580 - 25592
Published: Nov. 2, 2024
Multidrug
resistance
(MDR)
has
long
been
a
fundamental
obstacle
in
tumor
chemotherapy.
MDR
is
often
associated
with
overexpression
of
an
adenosine
triphosphate
(ATP)-binding
cassette
transporter
resistant
cancer
cells,
which
highly
ATP-dependent.
Therefore,
reversing
by
down-regulated
ATP
expression
promising
strategy.
This
study
developed
redox-regulating
nanotherapeutic
for
boosting
ferroptosis,
MDR,
and
inducing
synergistic
therapy.
Fe(III)-chelated
polydopamine
(Fe-PDA)
the
key
to
design
such
nanotherapeutic,
laser
irradiation
can
speed
up
electron
transfer
between
Fe3+
Fe2+
production
hydroxyl
radical
(•OH).
Coating
layer
Fe-PDA
on
surface
mesoporous
silica
(MSN)-encapsulated
diallyl
trisulfide
(DATS),
doxorubicin
(DOX)
was
loaded
Fe-PDA.
Upon
triggering,
(DATS@MSN@Fe-PDA/DOX,
DMFPD)
produced
photothermal
(•OH)
hydrogen
sulfide
(H2S)
apoptotic
cell
death.
The
DATS
depleted
intracellular
glutathione
(GSH),
together
H2S
boosted
ferroptosis.
Ferroptosis
effectively
caused
mitochondrial
dysfunction,
thereby
suppressing
expression.
interactive
death
chemotherapy
sensitization
were
further
demonstrated
4T1
tumor-bearing
mouse
model
high
level
biosafety.
provides
strategy
clinical
theragnostics.
Language: Английский
Recent developments in photothermal therapy: a bibliometric and visual analysis
Runying Guo,
No information about this author
Rongrong Zhang,
No information about this author
Yuqi Xin
No information about this author
et al.
Journal of Biomaterials Science Polymer Edition,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 21
Published: Dec. 8, 2024
Photothermal
therapy
(PTT)
has
recently
garnered
significant
attention
as
a
prominent
noninvasive
treatment
modality
for
broad
spectrum
of
diseases.
Despite
the
increasing
volume
scholarly
output
over
last
20
years,
holistic
synthesis
that
delineates
worldwide
research
trajectories
remains
elusive.
We
undertook
bibliometric
analysis
literature
from
2004
to
2023,
aiming
delineate
prevailing
focal
points
and
illuminate
prospective
avenues.
Research
articles
on
PTT
were
retrieved
Web
Science
Core
Collection.
Using
tools
such
CiteSpace,
VOSviewer,
Bibliometrix,
we
comprehensively
analyzed
visualized
11,184
published
academic
papers.
China
highest
number
publications.
Journals
related
are
primarily
comprised
interdisciplinary
comprehensive
journals.
associated
with
focused
its
antitumor
properties.
Current
areas
in
this
domain
include
synergistic
combination
photodynamic
therapy,
immunological
mechanisms
enhance
therapeutic
efficacy,
integrated
use
nanoenzyme
catalysis,
role
antimicrobial
applications.
This
provides
an
initial
examination
medical
applications
PTT,
offering
insights
into
global
landscape,
key
interest,
emerging
trends,
thereby
serving
valuable
reference
future
studies
field.
Language: Английский
Glutathione-Responsive Nanoplatforms Based on Coordination between Fe3+ and Apigenin for Synergistic Chemo/Chemodynamic Therapy
Zhi-Hang He,
No information about this author
Hanxiao Tang,
No information about this author
Yanna Pan
No information about this author
et al.
ACS Applied Nano Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 10, 2024
The
oxygen
consumption
during
chemodynamic
therapy
(CDT)
can
lead
to
severe
cellular
hypoxia,
resulting
in
an
increase
the
hypoxia
inducible
factor-1α
(HIF-1α)
level,
which
hinders
effectiveness
of
CDT
and
induces
tumor
metastasis.
Here,
we
propose
a
strategy
synergistic
between
HIF-1α
inhibitor
avoid
limitations
reduce
risk
Herein,
based
on
coordination
Fe3+
apigenin
(API,
inhibitor),
constructed
hyaluronic
acid
(HA)-modified
API-Fe
nanoparticles
(AF@HA
NPs)
for
synergetic
chemotherapy
glutathione
(GSH)-activated
self-enhancing
CDT.
AF@HA
NPs
have
high
drug
loading
capacity,
stability,
biocompatibility.
Furthermore,
overexpressed
GSH
cancer
cells
Fe2+,
weakened
API
Fe,
promoted
release
chemotherapy.
Fe2+
could
react
with
endogenous
H2O2
generate
hydroxyl
groups
In
addition,
released
inhibit
expression
sensitivity
reactive
species
(ROS),
thereby
achieving
effect
results
vitro
vivo
experiments
indicated
that
effectively
growth
suppress
lung
metastasis
cells.
Language: Английский